OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.2548 USD -0.41% Market Closed
Market Cap: $963.3m

Net Margin

-28.1%
Current
Declining
by 5%
vs 3-y average of -23.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-28.1%
=
Net Income
$-180.4m
/
Revenue
$642.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-28.1%
=
Net Income
$-180.4m
/
Revenue
$642.1m

Peer Comparison

Country Company Market Cap Net
Margin
US
OPKO Health Inc
NASDAQ:OPK
960.9m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
383.2B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.2B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
181.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.9B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.7B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 77% of companies in the United States of America
Percentile
23nd
Based on 15 072 companies
23nd percentile
-28.1%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

OPKO Health Inc
Glance View

In the bustling world of healthcare and biotechnology, OPKO Health Inc. stands as a unique and dynamic player. Founded by the ambitious mind of Dr. Phillip Frost, the company has woven itself into the fabric of diverse biomedical sectors. OPKO predicates its enterprise on the integration of complementary businesses ranging from diagnostics to pharmaceuticals, creating synergies that are not just theoretical, but markedly operational. At the heart of its operations lies the interplay between new drug discovery and diagnostics development, allowing OPKO to leverage cutting-edge technologies in crafting novel health solutions. By honing in on significant medical unmet needs, they aspire to deliver innovations that address chronic diseases such as diabetes, oncology, and neurological disorders. This strategic weaving together of distinct healthcare sectors manifests in OPKO's sprawling portfolio—from the renowned Rayaldee, which targets secondary hyperparathyroidism, to its advanced diagnostics segments, which include proprietary tests for specific cancers and other conditions. The company's revenue streams can be best visualized as an interlocking lattice of healthcare services and products. It earns through a blend of product sales, licensing, and collaborative agreements with other biotech and pharmaceutical giants. Rayaldee, as a potent testament to their R&D prowess, contributes robustly to their revenue, while the diagnostics division, powered by their substantial investment in technology and infrastructure, brings in consistent sales from various testing services. The company’s BioReference Laboratories, one of the largest full-service diagnostic laboratories in the U.S., also plays a critical role in their financial architecture, offering both routine and esoteric tests. Additionally, OPKO is involved in strategic collaborations and licensing arrangements, enhancing its market footprint and creating channels for revenue infusion through partnerships with industry leaders. Ultimately, OPKO Health Inc.'s narrative is one of leveraging diversified capabilities and strategic partnerships to carve out a formidable presence in the complex landscape of global healthcare.

OPK Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-28.1%
=
Net Income
$-180.4m
/
Revenue
$642.1m
What is OPKO Health Inc's current Net Margin?

The current Net Margin for OPKO Health Inc is -28.1%, which is below its 3-year median of -23.1%.

How has Net Margin changed over time?

Over the last 3 years, OPKO Health Inc’s Net Margin has decreased from -26% to -28.1%. During this period, it reached a low of -33.9% on Jun 30, 2024 and a high of -5.7% on Mar 31, 2025.

Back to Top